Literature DB >> 31866408

Hydroxysafflor yellow A actives BKCa channels and inhibits L-type Ca channels to induce vascular relaxation.

Na Wang1, Dongmei He1, Yuanqun Zhou1, Jing Wen1, Xiaoqin Liu1, Pengyun Li1, Yan Yang2, Jun Cheng3.   

Abstract

Hydroxy-safflor yellow A (HSYA) can exert a variety of effects upon the vascular system. However, the underlying mechanisms are not clear. The present study is to investigate its vasodilating effect and the mechanisms. Wistar-Kyoto (WKY) rats and spontaneously hypertensive rats (SHR) were enrolled for studying effects of HSYA on blood pressure, vasodilation, intracellular Ca2+ transient and membrane ion channels. Vasodilation and intracellular Ca2+ transient were measured by using vasomotor assay and fluorescence imaging system, respectively. The effect of HSYA on the large conductance Ca2+ activated and voltage-gated potassium channel (BKCa channel) currents in rat mesentery artery and on L-type calcium channel (Ca-L) currents in HEK293cells expressed with Ca-L were investigated using patch clamp techniques. Blood pressure of SHR and WKY rats were concentration dependently reduced by HSYA with a larger effect of HSYA in SHR than that in WKY rats. The tension of mesenteric arteries induced by 3 μM phenylephrine was attenuated by HSYA (IC50 = 90.8 μΜ). Patch clamp study showed that HSYA could activate BKCa channels and suppress Ca-L channels in a concentration dependent manner. The results of calcium signaling assays indicated that HSYA could reduce the intracellular free Ca2+ level. These findings demonstrate that HSYA could activate BKCa channels and inhibit Ca-L channels and reduce intracellular free Ca2+ level, which are probably important for its vasodilatory effect.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BK(Ca); Hydroxysafflor yellow a; L-type Ca channel; Smooth muscle cells; vasodilatation

Mesh:

Substances:

Year:  2019        PMID: 31866408     DOI: 10.1016/j.ejphar.2019.172873

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

Review 1.  Pharmacological Activities of Safflower Yellow and Its Clinical Applications.

Authors:  Yan Chen; Meifeng Li; Jiayu Wen; Xiaoqi Pan; Zixin Deng; Junren Chen; Guanru Chen; Lei Yu; Yunli Tang; Gangmin Li; Xiaofang Xie; Cheng Peng
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-27       Impact factor: 2.650

Review 2.  Hydroxysafflor yellow A improved retinopathy via Nrf2/HO-1 pathway in rats.

Authors:  Zhihui Sun; Yuanyuan Wang; Rui Xu; Shitong Zhang; Hongtao Yang; Jingjing Song; Tao Chang
Journal:  Open Life Sci       Date:  2022-03-24       Impact factor: 0.938

3.  Hydroxysafflor Yellow A Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Calcium Overload and Apoptosis.

Authors:  Jingxue Ye; Ruiying Wang; Min Wang; Jianhua Fu; Qiong Zhang; Guibo Sun; Xiaobo Sun
Journal:  Oxid Med Cell Longev       Date:  2021-05-21       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.